GlobalData on MSN3d
Sanofi moves closer to selling controlling stake in $17bn-valued Opella
Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.
Drug Store News3d
Sanofi nears selling 50% controlling stake in Opella to CD&R
Sanofi is closer to selling a 50% controlling stake in the consumer health business, Opella to private equity Clayton ...
Sanofi to sell 50% stake in consumer health unit to CD&R
Sanofi ( NASDAQ: SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, ...
Nasdaq4d
Sanofi Signs Share Purchase Deal To Sell 50% Controlling Stake In Opella To CD&R
The valuation of Opella was then based on an enterprise value of 16 billion euros. Sanofi now said the agreement follows completion of the required social and corporate procedures. Bpifrance is ...
Press Release: Sanofi and CD&R sign Opella share purchase agreement
Sanofi and CD&R sign Opella share purchase agreementParis, February 19, 2025. Following completion of the required social and corporate ...
Morningstar4d
Press Release: Sanofi and CD&R sign Opella share purchase agreement
Bpifrance is expected to participate as a minority shareholder with a c.2% stake in Opella, with Sanofi remaining a significant shareholder. The terms of the transaction remain unchanged from ...
Finanznachrichten4d
Sanofi: Sanofi and CD&R sign Opella share purchase agreement
Bpifrance is expected to participate as a minority shareholder with a c.2% stake in Opella, with Sanofi remaining a significant shareholder. The terms of the transaction remain unchanged from ...